Evaluating the Effect of Artificial Liver Support on Acute-on-Chronic Liver Failure Using the Quantitative Difference...

Area of Science:

• Hepatology
• Medical Prognostics
• Biomarker Discovery

Background:

• Acute-on-chronic liver failure (ACLF) presents a significant challenge due to high mortality and costs.
• Prognosis evaluation is critical throughout the ACLF treatment journey.
• The quantitative difference (QD) algorithm is a novel tool for improving ACLF prognosis assessment.

Purpose of the Study:

• To compare the efficacy of the QD algorithm against the established Model for End-Stage Liver Disease (MELD) score for ACLF prognosis.
• To determine if the QD algorithm offers superior or comparable performance to MELD.

Main Methods:

• A cohort of 27 ACLF patients was divided into conventional treatment (n=12) and double plasma molecular absorption system (DPMAS) plus conventional treatment (n=15) groups.
• Prognosis was evaluated using both MELD and QD scoring systems.
• Treatment outcomes and specific clinical markers were analyzed.

Main Results:

• The QD algorithm demonstrated significant reductions in liver enzymes and bilirubin, correlating with therapeutic effects.
• A significant association was found between MELD and QD values (P<.001).
• The QD algorithm indicated improvements in patient fatigue and showed dynamic evaluation capabilities.

Conclusions:

• The QD scoring system effectively evaluates therapeutic effects in ACLF patients, similar to MELD.
• The QD algorithm surpasses MELD by integrating a wider array of indicators and accounting for individual patient variability.
• QD offers a dynamic and comprehensive approach to ACLF prognosis.